semaglutide and depression medication Novo Nordisk is suing Eli Lilly over its GLP-1 ads, accusing the rival drugmaker of false advertising for claiming Lilly's Mounjaro Zepbound outperform Novo's Ozempic and Wegovy. MORE BELOW ⬇️ glp-1 pancreatitis class action in
Pay in 4 interest-free payments of $6.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30















![Mounjaro Eye Side Effects Lawsuit [2026 Update]](https://www.robertkinglawfirm.com/wp-content/uploads/2024/08/mounjaro-eye-side-effects-lawsuit.webp)





